Expression of the hepatocyte growth factor/c‐Met pathway is increased at the cancer front in breast carcinoma
- 1 March 2001
- journal article
- research article
- Published by Wiley in Pathology International
- Vol. 51 (3) , 172-178
- https://doi.org/10.1046/j.1440-1827.2001.01182.x
Abstract
Expression of hepatocyte growth factor (HGF) and c‐Met (HGF receptor) has been reported in many neoplasms. We investigated coexpression of HGF and c‐Met to determine the role of the HGF/c‐Met pathway...Keywords
This publication has 27 references indexed in Scilit:
- Hepatocyte growth factor/scatter factor expression and c-met in primary breast cancerSurgical Oncology, 1996
- Hepatocyte growth factor/scatter factor induces a variety of tissue-specific morphogenic programs in epithelial cells.The Journal of cell biology, 1995
- C-met Proto-Oncogene Expression in Benign and Malignant Human Prostate TissuesJournal of Urology, 1995
- Expression of the c-met protooncogene in human hepatocellular carcinomaHepatology, 1994
- Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth.The Journal of cell biology, 1992
- The met Proto-Oncogene Receptor and Lumen FormationScience, 1992
- Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene ProductScience, 1991
- Molecular cloning and expression of human hepatocyte growth factorNature, 1989
- Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factorBiochemical and Biophysical Research Communications, 1989
- Autocrine Secretion and Malignant Transformation of CellsNew England Journal of Medicine, 1980